These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35693394)

  • 21. Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease.
    Simental-Mendía LE; Gamboa-Gómez CI; Guerrero-Romero F; Simental-Mendía M; Sánchez-García A; Rodríguez-Ramírez M
    Adv Exp Med Biol; 2021; 1308():257-272. PubMed ID: 33861449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The associations between physical activity intensity, cardiorespiratory fitness, and non-alcoholic fatty liver disease.
    Kerr CJ; Waterworth SP; Brodie D; Sandercock GRH; Ingle L
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3508-3514. PubMed ID: 34427948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey.
    Saeed N; Glass LM; Habbal H; Mahmood A; Sengstock D; Saini SD; Tincopa MA
    Therap Adv Gastroenterol; 2021; 14():17562848211042200. PubMed ID: 34567270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
    Yim JY; Kim J; Kim D; Ahmed A
    Liver Int; 2018 Nov; 38(11):2051-2059. PubMed ID: 29517842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and risk factors of non-alcoholic fatty liver disease in
    Siddiqui B; Kamran M; Tikmani SS; Azmat R; Mushtaq Z; Zafar SB; Khan MT; Yakoob J; Abbas Z
    SAGE Open Med; 2021; 9():20503121211025421. PubMed ID: 34211711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study.
    Wang Q; Zheng D; Liu J; Fang L; Li Q
    Lipids Health Dis; 2018 Dec; 17(1):284. PubMed ID: 30545385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.
    Milovanovic T; Pantic I; Dragasevic S; Lugonja S; Dumic I; Rajilic-Stojanovic M
    J Gastrointestin Liver Dis; 2021 Jun; 30(2):274-282. PubMed ID: 33951119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.
    Gökmen FY; Ahbab S; Ataoğlu HE; Türker BÇ; Çetin F; Türker F; Mamaç RY; Yenigün M
    Clinics (Sao Paulo); 2016 Apr; 71(4):221-5. PubMed ID: 27166773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new risk factor for the development of non-alcoholic fatty liver disease: HLA complex genes.
    Celıkbılek M; Selçuk H; Yilmaz U
    Turk J Gastroenterol; 2011 Aug; 22(4):395-9. PubMed ID: 21948570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating causality of cellular senescence in non-alcoholic fatty liver disease.
    Meijnikman AS; Herrema H; Scheithauer TPM; Kroon J; Nieuwdorp M; Groen AK
    JHEP Rep; 2021 Aug; 3(4):100301. PubMed ID: 34113839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases].
    Chen HT; Zhou YJ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):203-207. PubMed ID: 32306652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease and associated risk factors in health care professionals in a community hospital in Brazil.
    Magalhães VDS; Jost TDA; Pasqual HM; Becker ALG; Marques LM; Manica M; Delani BLL; Langaro JP; Afonso DT; Hoppe L; Orsolin A; Vartha APP
    Rev Bras Med Trab; 2021 Mar; 18(4):449-456. PubMed ID: 33688327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research progress of non-alcoholic fatty liver disease in postmenopausal women].
    Zhang Q; Guo JH; Zhou LS; Dong H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):629-632. PubMed ID: 32791802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease.
    Amir M; Yu M; He P; Srinivasan S
    Front Med (Lausanne); 2020; 7():62. PubMed ID: 32175323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical approach to non-alcoholic fatty liver disease in patients with diabetes.
    Tai FW; Syn WK; Alazawi W
    Diabet Med; 2015 Sep; 32(9):1121-33. PubMed ID: 25683343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipidomics in non-alcoholic fatty liver disease.
    Kartsoli S; Kostara CE; Tsimihodimos V; Bairaktari ET; Christodoulou DK
    World J Hepatol; 2020 Aug; 12(8):436-450. PubMed ID: 32952872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
    Zawdie B; Tadesse S; Wolide AD; Nigatu TA; Bobasa EM
    Ethiop J Health Sci; 2018 Jan; 28(1):19-30. PubMed ID: 29622904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.